Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1618)
Reports (60)
SAGE documentation (226)
Scientific publications (120)
Systematic reviews (SYSVAC) (2973)
Regions
Africa (292)
Americas (777)
Eastern Mediterranean (56)
Europe (728)
Global (1)
South-East Asia (82)
Western Pacific (210)
Diseases
Chikungunya (11)
Cholera (35)
COVID-19 (1552)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (83)
Ebola (17)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (69)
Hepatitis A (65)
Hepatitis B (163)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (73)
HIV / AIDS (10)
Human papillomavirus (HPV) (515)
Influenza (610)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (31)
Measles (139)
Meningococcal disease (151)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (47)
Pertussis (113)
Pneumococcal disease (292)
Poliomyelitis (89)
Q fever (1)
Rabies (31)
Rotavirus (118)
RSV (Respiratory syncytial virus) (58)
Rubella (66)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (64)
Tick-borne encephalitis (12)
Tuberculosis (79)
Typhoid (27)
Varicella (75)
Yellow fever (44)
Zika (1)
Show more
5037 results found
2023
∙
Commission Technique des Vaccinations
Vaccination strategy against Covid-19: anticipation of vaccination campaigns in 2023
2023
∙
NACI
Recommendation on Repeated Seasonal Influenza Vaccination
2023
∙
ATAGI
ATAGI 2023 booster advice
2023
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
2023
Updated HPV Technical Dossier on Quadrivalent HPV (Gardasil-4valent) 1-dose Regimen
2023
∙
Conseil Supérieur de la Santé (CSS)
Pneumococcal vaccination in children and adolescents in Belgium
2023
∙
NACI
NACI guidance on COVID-19 vaccine booster doses: Initial considerations for 2023
2023
∙
NIAC
Recommendations for COVID-19 vaccination of children aged 6 months to 4 years
2022
∙
Borra, S. S. Narenthiran, C. K. Kumar, D. Ayilya, M. Sadagoban, G. K.
A Comprehensive Review on Efficacy and Adverse Events Associated With Different Covid-19 Vaccines
2022
∙
Dhanani, Lindsay Y. Franz, Berkeley
A Meta-Analysis of COVID-19 Vaccine Attitudes and Demographic Characteristics in the United States
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register